Search Results - clinical+and+disease+specializations+%3e+oncology

361 Results Sort By:
A method for inhibiting UHRF1 in colorectal cancer
Value PropositionReversal of colorectal cancer-specific DNA hypermethylationmRNA-based strategy for UHRF1 inhibitionA lipid nanoparticle-based delivery platformUnmet Need1 out of 24 people will develop colorectal cancer. Current technologies do not maximize the bodies’ native ability to suppress tumors. Existing therapies lack specificity and cause...
Published: 9/12/2025   |   Inventor(s): Stephen Baylin, Srinivasan Yegnasubramanian, Ying Cui, Xiangqian Kong
Keywords(s):  
Category(s): Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities > Therapeutic Delivery Platforms, Technology Classifications > Research Tools > Nucleic Acids, Technology Classifications > Therapeutic Modalities > Peptides, Technology Classifications > Therapeutic Modalities > Proteins, Technology Classifications > Research Tools > Proteins, Ligands & Receptors
In vivo and in vitro Role of Lactosylceramide Synthase (LCS) in Angiogenesis and LCS (B1, 4GalT-V) as a Bio-marker for Human Colon Cancer
Description:   C10539: Use of Biomarker for Colon Cancer Diagnosis Value Proposition: ADVANTAGES • Colon cancer biomarker is directly included in panels of biomarkers for use in needle biopsies of colon tissue for early detection and diagnosis. • Colon cancer is the second largest mortality after cardiovascular disease. 90% of colorectal cancers...
Published: 9/11/2025   |   Inventor(s): Subroto Chatterjee
Keywords(s): Antagonists/Inhibitors, Biomarker, Cancers, Clinical Diagnostics, Colorectal Cancer, Diagnostic Biomarker, Disease Indication, In Vitro Diagnostics, Novel, Predicted Novelty, Small Molecules, Therapeutic Matter, Therapeutic Substance, Therapeutics
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Gastroenterology, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications > Diagnostics > Diagnostic Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Therapeutic Modalities > Small Molecules, Technology Classifications > Diagnostics, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities, Clinical and Disease Specializations > Oncology > Colorectal Cancer
A Method to Conditionally Deliver Effector Proteins to Plasma and Endosomal Membranes in Response to Tyrosine Kinase Signaling
JHU Ref #: C17482Value Proposition·        Effective & Targeted: Harnesses endogenous pain signaling via receptor tyrosine kinases to conditionally deliver effector proteins to the plasma membrane, enabling suppression of chronic pain under pathological conditions·        Broadly Applicable: Enables modular, tunable therapy tailored to the prevailing...
Published: 9/12/2025   |   Inventor(s): Michael Caterina, Stephen Gould, Shang-Jui Tsai
Keywords(s):  
Category(s): Clinical and Disease Specializations > Pain > Chronic Pain, Technology Classifications > Therapeutic Modalities > Proteins, Clinical and Disease Specializations > Neurology, Clinical and Disease Specializations > Oncology
Compositions and Biomarkers for Human Cancer and Methods of Use
Novel biomarkers for the detection and prognosis of several cancersJHU REF: C12506  Invention novelty: This invention has discovered high frequency mutations in the telomerase reverse transcriptase (TERT) promoter of certain cancers.   Value Proposition: Early detection is usually critical for the successful treatment of cancer, therefore there is...
Published: 9/11/2025   |   Inventor(s): Bert Vogelstein, Kenneth Kinzler, Nickolas Papadopoulos, Chetan Bettegowda, Yuchen Jiao, Darell Bigner, Hai Yan, Zachary Reitman, Patrick Killela
Keywords(s): Biomarker, Cancers, Clinical Diagnostics, Disease Indication, In Vitro Diagnostics, Mechanism-of-action Biomarker, Therapeutic Matter, Therapeutics
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Diagnostics > Prognostic Biomarkers, Technology Classifications > Diagnostics > In Vitro Diagnostics, Technology Classifications > Diagnostics > Diagnostic Biomarkers, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Diagnostics, Technology Classifications > Therapeutic Modalities
Novel monoclonal antibody inhibitors targeting potassium channel KCNK9
Unmet Need:KCNK9 is one of 15 mammalian subtypes in the highly conserved family of two-pore domain potassium channels (K2P). Under physiological conditions, KCNK9 is primarily expressed in the brain where it serves to maintain cellular membrane potentials. However, overexpression of KCNK9 has been detected in breast, lung, skin, and other cancers, and...
Published: 9/11/2025   |   Inventor(s): John Laterra, Han Sun, Min Li, Amy Fulton
Keywords(s): Antibodies, Biologics, Breast Cancer, Cancers, Disease Indication, Lung Cancer, Therapeutic Matter, Therapeutic Substance, Therapeutics
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Respiratory Diseases, Clinical and Disease Specializations > Women's Health, Technology Classifications > Therapeutic Modalities > Antibodies, Technology Classifications > Therapeutic Modalities > Biologics, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities, Clinical and Disease Specializations > Oncology > Breast Cancer, Clinical and Disease Specializations > Oncology > Lung Cancer
AI-Powered Brain Tumor Prognosis Tool Post-Surgery
Value Proposition: Combines MRI imaging and clinical variables for a comprehensive and accurate prediction of brain tumor outcomes and can automates complex analyses to save time for clinicians while supporting personalized patient counseling and optimized treatment strategies. Demonstrates proven accuracy through validation on 600 glioblastoma...
Published: 9/12/2025   |   Inventor(s): Julian Gendreau, Yuncong Mao, Linda Tang, Melanie Alfonzo Horowitz, Saket Myneni, Jacob Gould, Karim Ahmed
Keywords(s):  
Category(s): Clinical and Disease Specializations > Oncology, Clinical and Disease Specializations > Oncology > Glioblastoma, Technology Classifications > Computers, Electronics & Software > Artificial Intelligence, Technology Classifications > Computers, Electronics & Software > Machine Learning, Technology Classifications > Computers, Electronics & Software > Precision Medicine Tools
Methylated Markers for the Detection of Cervical Cancer
Unmet need:According to WHO, cervical cancer represents the fourth most common female cancer world-wide, with approximately 600,000 new cases as well as 300,000 deaths in 2020 alone (see WHO). Cervical cancer screening efforts aim to detect cancerous lesions in the cervix to enable earlier treatment. The main screening modalities include a Pap test...
Published: 9/12/2025   |   Inventor(s): Saraswati Sukumar, MaryJo Fackler, Deyin Xing
Keywords(s):  
Category(s): Clinical and Disease Specializations > Oncology, Clinical and Disease Specializations > Oncology > Cervical Cancer, Technology Classifications > Diagnostics > Biomarkers, Technology Classifications, Technology Classifications > Diagnostics
Targeted Antineoplastic Therapeutic for Cancers with High Translation Rates
Value Proposition:Targeted cancer therapeutic and combination therapy to prevent resistanceTarget cancer cell’s vulnerable translation processesTarget aggressive cancers with poor prognoses at present Technology DescriptionThe disclosed technology addresses the major challenge of identifying selective drug therapies that kill cancer cells, without affecting...
Published: 9/12/2025   |   Inventor(s): Rachel Green, Sergi Regot, Niladri Sinha, Connor McKenney
Keywords(s):  
Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities
Methods for in situ Detection of DNA Sequence Variation
Value Proposition·        High-throughput·        Assess genetic variants with simultaneous spatial analysis·        Interrogate over 100 variants in a single assayUnmet Need·        Next generation sequencing has led to an ever-proliferating dearth of genetic information. More recent progress in nucleoside tissue analysis has birthed the field of spatial...
Published: 9/12/2025   |   Inventor(s): Reza Kalhor, Soichiro Asami
Keywords(s):  
Category(s): Technology Classifications, Clinical and Disease Specializations > Oncology, Technology Classifications > Research Tools > Assays, Technology Classifications > Research Tools > Antibodies, Technology Classifications > Research Tools > Bioinformatics, Technology Classifications > Research Tools > Imaging, Technology Classifications > Research Tools > Nucleic Acids
Non-contact Ultrasound Tomography Imaging System
Multifunctional 3D ultrasound imaging systemJHU Ref #: C17859Value Proposition:·        Generation of high resolution 3D images for detection and diagnosis of diseases.·        Overcomes previous required use of media (water) to image.·        Media-less imaging ability allows for integration of other imaging techniques (MRI, PET, CT). Unmet Need·        The...
Published: 9/12/2025   |   Inventor(s): Jeeun Kang, Emad Boctor, Hyunwoo Song, Yixuan Wu
Keywords(s):  
Category(s): Clinical and Disease Specializations > Oncology, Clinical and Disease Specializations > Oncology > Breast Cancer, Technology Classifications > Diagnostics, Technology Classifications > Diagnostics > Diagnostic Imaging, Technology Classifications > Medical Devices > Imaging
1 2 3 4 5 6 7 8 9 10 ...
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum